Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Vaccine

Cases of monkeypox increase in Scotland amid 'limited' vaccine supply

HEALTH chiefs are working to access more vaccines which protect against monkeypox after cases in Scotland rose again.

The National (Scotland)

Monkeypox cases in Scotland increase as health chiefs battle to get more vaccines

Public Health Scotland (PHS) said there have now been 79 laboratory confirmed cases of the disease.

Daily Record

Kyle Sandilands Is Getting Rightfully Roasted For His Absolutely Fkd Comments About Monkeypox

"Comments such as this are not just hurtful, they are also deeply unhelpful."

Pedestrian.tv

From analysis to the latest developments in health,
read the most diverse news in one place.

Covid-19: Bihar crosses 15 crore-mark of administering vaccine doses

PATNA: The state has crossed 15 crore Covd-19 vaccination mark on Friday and the stress is now on administering precautionary doses to those who have become eligible, as well as vaccinating children above 12 years, if they have missed their shots.

The Times of India

Early signs suggest monkeypox may be slowing in the U.S.

Rates of new cases are declining in major cities, suggesting public health campaigns are working.

WEKU

Recap Of Friday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has approved Incyte’s (NASDAQ:INCY) Pemazyre (pemigatinib), a selective fibroblast growth factor receptor (FGFR) inhibitor, for the treatment of adults with relapsed or refractory myeloid/lymphoid neoplasms (MLNs) with FGFR1 rearrangement. Incyte shares traded in a range of $71.38 to $72.98 on day volume of 1.25…

Benzinga

Federal officials hopeful about monkeypox trajectory

Federal health officials expressed cautious optimism Friday about the trajectory and spread of the monkeypox outbreak, emphasizing that increased vaccination, harm reduction behaviors and educational and outreach efforts appear to be helping to curb the spread.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

HSE warn of measles symptoms and risks as 'worrying' drop in children's vaccination rates seen

Today’s warning comes after recent data from the Health Protection Surveillance Centre showed a "worrying drop in the uptake of childhood vaccines in two-year-olds"

Irish Mirror

Monkeypox vaccine supply now sufficient, Biden officials say

The Biden administration says it has shipped enough monkeypox vaccine to deliver the first of two doses to all of the 1.6 million people identified to be at highest risk of infection from the virus

The Independent UK

Moderna Sues Pfizer/BioNTech for Patent Infringement over COVID Vaccine

Moderna sued Pfizer and its German partner BioNTech on Friday for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic. Pfizer shares fell nearly 1%, while BioNTech US-listed shares were down about 1.5%…

Asharq Al-Awsat

Federal officials hopeful about monkeypox trajectory - Roll Call

The U.S. reported 17,000 cases of monkeypox as of Thursday, of the more than 46,700 cases detected globally.

Roll Call

US Covid vaccine maker Moderna suing rivals Pfizer and BioNTech over jab

The company said it believes its rivals’ vaccine infringes on patents Moderna filed between 2010 and 2016

Wales Online

USDA scattering rabies vaccines for wildlife in 13 states

The U.S. government has begun scattering millions of packets of oral rabies vaccine from helicopters and planes in 13 states from Maine to Alabama

The Independent UK

Pfizer asks EU drug regulator to OK tweaked COVID vaccine

Pharmaceuticals Pfizer and BioNTech say they have asked the European Medicines Agency to authorize their updated coronavirus booster vaccine that includes the most recent omicron subvariants

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU

Moderna sues Pfizer over COVID-19 vaccine patents

The vaccine maker alleges that its rivals Pfizer and BioNTech used some patented features of its mRNA technology to develop their COVID vaccines.

The Independent UK

Moderna sues Pfizer and BioNTech over Covid-19 vaccine

The vaccine maker said it had filed patent infringement lawsuits in the US and Germany.

Evening Standard

Moderna sues Pfizer/BioNTech alleging patent infringement over Covid vaccine

Moderna seeks unspecified damages in lawsuit over rivals’ jab

The Independent UK

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

Get all your
news in one place.

100's of premium titles.
One news app.

Wales Online

Pharmacy chain advises women to reduce threat of HPV by having vaccine

HPV has no symptoms, and most people will be infected with some type of the virus at some time in their life.

Bangkok Post

Thonburi Healthcare chairman resigns after market ban

Dr Boon Vanasin, the founder and chairman of Thonburi Healthcare Group (THG), is resigning from the company’s board as he faces a market ban in connection with claims he made last year about the purchase of Pfizer coronavirus vaccines.

Tribune News Service

Moderna sues Pfizer, BioNTech over COVID vaccine technology

Moderna Inc. sued Pfizer Inc. and BioNTech SE, claiming the technology in their COVID-19 shot infringes on its patents, a move that sets the stage for a massive legal clash between the vaccine titans.

Bangkok Post

Moderna sues Pfizer over Covid vaccine

Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first Covid-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic.

The Independent UK

Moderna sues Pfizer over patents behind COVID-19 vaccine

COVID-19 vaccine maker Moderna is suing its main competitors Pfizer and the German drugmaker BioNTech, accusing the rivals of copying Moderna’s technology in order to make their own vaccine

The Independent UK

Moderna sues Pfizer-BioNTech accusing them of copying Covid shot technology

‘We believe that Pfizer and BioNTech unlawfully copied Moderna’s inventions, and they have continued to use them without permission,’ Moderna legal officer says

StockNews.com

Is Pfizer a Buy Before New Omicron Boosters Roll Out?

Pharmaceutical giant Pfizer’s (PFE) omicron-targeted booster doses could soon be authorized this fall. The company has benefited largely from the pandemic and its vaccine rollouts. Now let’s find out if PFE is a Buy now as it prepares to roll out its booster doses….

1 … 197 198 199 200

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Public Health Scotland

254 stories

Sydney Morning Herald

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.